Halopropane Explained
Halopropane (synonym FHD-3, trade name Tebron) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.[1] Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of teflurane and norflurane.[2] [3] [4]
See also
Notes and References
- Book: Webster NR, Galley HF . Landmark Papers in Anaesthesia. 22 August 2013. OUP Oxford. 978-0-19-163319-5. 70–.
- Book: Acta anaesthesiologica Belgica. 1974. Acta Medica Belgica..
- Book: Klein SL . A glossary of anesthesia and related terminology. registration. 1993. Springer-Verlag. 978-0-387-97831-4.
- Book: Catcott EJ, Smithcors JF . Progress in canine practice. 1973. American Veterinary Publications.